Let’s help the very sharp students out at Queen’s U.
Is it obvious enough yet? This is a business model. This is the business model. Because this is very big exploitative crony capitalist business!
As I’d previously written- not accessible via the wayback, sorry
The link outwards regarding ADE possibility takes you here
Abstract
Antibody-based drugs and vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are being expedited through preclinical and clinical development. Data from the study of SARS-CoV and other respiratory viruses suggest that anti-SARS-CoV-2 antibodies could exacerbate COVID-19 through antibody-dependent enhancement (ADE). Previous respiratory syncytial virus and dengue virus vaccine studies revealed human clinical safety risks related to ADE, resulting in failed vaccine trials.
From earlier today:
Wise Words
8 replies on “Mass Market Model: ADE’s, Leaky Vaccines and Breakthrough Infections”
[…] Mass Market Model: ADE’s, Leaky Vaccines and Breakthrough Infections […]
[…] Mass Market Model: ADE’s, Leaky Vaccines and Breakthrough Infections […]
[…] Mass Market Model: ADE’s, Leaky Vaccines and Breakthrough Infections […]
[…] Mass Market Model: ADE’s, Leaky Vaccines and Breakthrough Infections […]
[…] Mass Market Model: ADE’s, Leaky Vaccines and Breakthrough Infections […]
[…] Mass Market Model: ADE’s, Leaky Vaccines and Breakthrough Infections Wither the Vaccine Passport. It’s Claimed Purpose For Being Has Ended Vaccine Passports Could Actually Help Spread Covid. Here’s Why… […]
[…] Flashback: Covid Vaccine Guinea Pigs…ADE Increased Risk of Severe Disease Scientists Debate How Much to LOWER THE BAR on Covid-19 Vaccine Potential- Disconcerting Mass Market Model: ADE’s, Leaky Vaccines and Breakthrough Infections […]
[…] Mass Market Model: ADE’s, Leaky Vaccines and Breakthrough Infections […]